Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Medicine / Busulfan als myelosuppressiven Agenten zur…
JoVE Journal
Medicine

A subscription to JoVE is required to view this content.

JoVE Journal Medicine
Busulfan als myelosuppressiven Agenten zur Erwirtschaftung stabiler Hochrangige Knochenmark Chimärismus bei Mäusen
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Journal (Medicine)
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Journal (Medicine)
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
 
Click here for the English version

Busulfan als myelosuppressiven Agenten zur Erwirtschaftung stabiler Hochrangige Knochenmark Chimärismus bei Mäusen

Article DOI: 10.3791/52553-v • 11:25 min • April 1st, 2015
April 1st, 2015 •
1, 1, 1,2, 1, 2, 1,3
1Department of Biomedical Physiology and Kinesiology, Simon Fraser University, 2The Biomedical Research Centre, University of British Columbia, 3Division of Neurology, Department of Medicine, Neuromuscular Disease Unit, VHHSC

Chapters

Tags

Medizin Busulfan Knochenmarktransplantation myelosuppressive Anlage Chimärismus hämatopoetische Stammzellen Immunbiologie Durchflusszytometrie
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter